Revive Therapeutics is a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases. Its cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. The company also explores the use of Bucillamine for the potential treatment of infectious diseases, including COVID-19.